Recently, the natural product mumbaistatin (Figure 7A) was identified as an extremely potent inhibitor (IC50 = 5 nM) of the glucose-6-phosphate translocase enzyme complex, an attractive target for the treatment of Type II diabetes (Vertesy et al. 2001). The gene discussed is SLC37A4; the disease is type 2 diabetes mellitus.